GlaxoSmithKline to slash costs, jobs as profits drop (AFP)
AFP - British pharmaceutical giant GlaxoSmithKline said Wednesday it would cut jobs and costs as it blamed a fall in third-quarter profits on sliding sales of controversial diabetes drug Avandia.
No comments:
Post a Comment